Cancer
The Cancer Dietitian’s Chocolate Avocado Pudding
Editor’s Note: The following recipe was written and shared with us by our friend Julie, the Cancer Dietitian. I cannot tell you how many people
Teva Data Suggest Sustained Benefits of Austedo in Tardive Dyskinesia Management
The Oversensitized Nervous System: Why Symptoms Fluctuate
Novel Immunotherapy Offers Bladder Cancer Patients a Path Beyond Surgery
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
Uveitis
Emerging Evidence: Common Vaccines May Shield Against Eye Inflammation
New Research Reveals Protective Link Between Routine Immunizations and Uveitis Prevention A comprehensive analysis of patient health records reported on Medscape has uncovered a promising
Idiopathic intracranial hypertension
Daniel’s CSF Shunt for Idiopathic Intracranial Hypertension
Editor’s Note: The following patient story was submitted to us by Daniel S.—an animal lover, sports fan, and former IIH patient. When you think about
Lupus
Belimumab Dose Spacing May Be an Option for Selected Patients With SLE in Sustained Remission
As reported on MedScape, gradually extending the interval between belimumab doses may allow carefully selected patients with systemic lupus erythematosus (SLE) in long-term remission to
Primary Biliary Cholangitis
FDA Grants Breakthrough Therapy Designation to Pemafibrate for Primary Biliary Cholangitis
As reported on PR Newswire, the US Food and Drug Administration has granted Breakthrough Therapy designation to Kowa’s investigational therapy K-808 (pemafibrate) for primary biliary
Rare Disease
Enfortumab Vedotin/Pembrolizumab Regimen Outperforms Neoadjuvant Chemotherapy in Resectable MIBC
As reported on The ASCO Post, perioperative treatment with enfortumab vedotin-ejfv plus pembrolizumab resulted in superior event-free survival, overall survival, and pathologic response rates compared
Ebola
Ebola Outbreak and Lessons Learned
As reported by the BBC, the Ebola outbreak in DR Congo was declared in May 2026 and is now the second worst on record with
Mast Cell Activation Syndrome
How to Improve the Chances of Getting Useful MCAS Test Results
Editor’s Note: The following article was originally written by Dr. Linda Bluestein. Linda Bluestein, MD, is a board-certified anesthesiologist and internationally recognized expert in hypermobility
obstructive sleep apnea
Samsung Expands FDA-Cleared Sleep Apnea Screening to Galaxy Ring
As reported on Gizmodo, Samsung has announced that its Galaxy Ring will soon support an FDA-cleared sleep apnea risk detection feature, making it the first
Harlequin syndrome
Raising Awareness of Christoph’s Rare Progressive Neurological Case
Editor’s Note: The following patient story was submitted to us by Christoph Muth, a 52-year-old German man currently residing in Thailand. I am living with
Major Depressive Disorder
Axsome Launches Phase 3 CLARITY Study of Solriamfetol for Depression Patients Experiencing Daytime Sleepiness
As reported by The Manila Times, Axsome Therapeutics has announced the initiation of its Phase 3 CLARITY clinical trial evaluating solriamfetol as a potential treatment
Rare Disease
Tuberculosis Drug Discovery Gets Smarter with AI at Texas A&M AgriLife
According to a press release from Texas A &M, researchers are using artificial intelligence to narrow drug choices and make shared data easier to use. Tuberculosis drug
Rare Disease
SpudCell: A Synthetic Cell that Grows and Reproduces
A team from Minnesota University has created a synthetic cell that includes lifeless chemicals and created a synthetic cell that will grow, reproduce, and even
Leukemia
Where the Pain Used to Be
Editor’s Note: Patient Worthy is honored to share this article from our friends at Elephants & Tea, originally written by Kiki Khan, a leukemia survivor.
Rare Disease
Jon’s Caregiver Story
Editor’s Note: This post was written and submitted to us by Jon Scheinman, and originally shared on LinkedIn. To see the article in its original
Diabetes Type 2
Lilly’s Retatrutide Achieves Strong Weight Loss and Glycemic Benefits in Two Phase 3 Obesity Studies
As reported on Drugs, Eli Lilly has reported positive topline findings from two additional Phase 3 trials of retatrutide, its investigational triple hormone receptor agonist
Asthma
AstraZeneca’s Triple-Inhaler Asthma Therapy Moves Closer to EU Approval
As reported on PharmaBiz, AstraZeneca has reached an important regulatory milestone in Europe after the European Medicines Agency’s Committee for Medicinal Products for Human Use
Breast Cancer
EMA Backs Enhertu Plus Pertuzumab as Potential New First-Line Standard for HER2-Positive Metastatic Breast Cancer
As reported on PharmaBiz, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive recommendation supporting approval of AstraZeneca
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
Some days, your best looks different—and that's okay.
Living with a chronic illness means your energy, symptoms, and abilities can change from day to day. If you only have 40% to give today and you gave that 40%, you still gave 100% of what you had.
Progress isn't measured by comparing yourself to your best day. It's measured by showing up for yourself in whatever way you're able. Give yourself the same compassion you would offer someone else.
#invisibleillness #chronicillness #RareDisease #inspirationalquote #motivationalquote #quote #PatientWorthy
The Life Raft Group #Gist #tumorsDiscover the NEW LRG Patient Registry and learn how its enhanced features are improving the patient experience while supporting the future of #GISTresearch. Register: bit.ly/PRWebinar2026#GIST
#PatientRegistry #RareDisease #CancerResearch
